ESC 365 - Long-term prognosis after dual antiplatelet therapy in hemodialysis patients following percutaneous coronary intervention with second-generation drug eluting stent

ESC Premium Access

Long-term prognosis after dual antiplatelet therapy in hemodialysis patients following percutaneous coronary intervention with second-generation drug eluting stent

Session: Poster Session 3 - Coronary artery disease - Epidemiology and outcomes 1

Topic: Epidemiology, Prognosis, Outcome

Speaker: Doctor A. Shimizu (Kitakyushu, JP)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Doctor Akiyoshi Shimizu

University of Occupational and Environmental Health, Kitakyushu (Japan)

0 follower

9 more presentations in this session

Acute infection not only related to type 2, but also to type 1 myocardial infarction. A large prospective study from the RICO survey

Speaker: Professor Y. Cottin (Dijon, FR)

Clinical outcome of patients with coronary artery ectasia

Speaker: Doctor D. Haberman (Rehovot, IL)

Long term survival in patients with stable coronary disease at the beginning of the twenty-first century: the CICCOR registry, a seventeen years, prospective, monocentric, cohort study

Speaker: Doctor J. Sanchez (Cadiz, ES)

STEMI treatment in octogenarians in the stent save a life initiative in Argentina

Speaker: Doctor F. Cohen (Buenos Aires, AR)

Long-term outcomes after percutaneous coronary intervention for stable coronary artery disease versus acute coronary syndromes.

Speaker: Professor G. Helft (Paris, FR)

Access the full session

Poster Session 3 - Coronary artery disease - Epidemiology and outcomes 1

Speakers: Doctor A. Shimizu, Professor Y. Cottin, Doctor D. Haberman, Doctor J. Sanchez, Doctor F. Cohen...

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources